India’s Bioeconomy Hits $195 bn in 2025 – BioE3 Policy & RDI Fund Drive Towards $300 bn Target by 2030
Union Minister of State for Science & Technology <strong>Dr Jitendra Singh</strong> announced that India’s <span class="key-term" data-definition="Bioeconomy — Economic activities that use biological resources, processes and principles to produce goods and services, contributing to GDP and employment (GS3: Economy)">Bioeconomy</span> grew to **$195 bn in 2025**, contributing about **4.8 % of GDP**, and is on track to reach **$300 bn by 2030**. The growth is driven by the <span class="key-term" data-definition="BioE3 Policy — ‘Biotechnology for Economy, Environment and Employment’ policy aimed at promoting sustainable biomanufacturing, precision therapeutics and climate‑resilient agriculture (GS3: Economy)">BioE3 Policy</span>, a ₹1 lakh‑crore <span class="key-term" data-definition="RDI Fund — Research, Development and Innovation fund of ₹1 lakh crore allocated to boost deep‑tech and biotech ventures (GS3: Economy)">RDI Fund</span>, and the support of <span class="key-term" data-definition="Biotech startups — Early‑stage companies developing biotechnology products or services; India hosts over 11,800 such firms (GS3: Economy)">biotech startups</span> through <span class="key-term" data-definition="BIRAC (Biotechnology Industry Research Assistance Council) — A government agency under the Department of Biotechnology that funds and supports biotech innovation and startups (GS3: Economy, GS4: Ethics)">BIRAC</span>.
India’s Bioeconomy has surged from roughly **$10 bn in 2014** to **$195 bn in 2025**, registering an annual growth of **17‑18 %**. Union Minister of State (Independent Charge) for Science & Technology, Dr Jitendra Singh , highlighted this expansion at the 14th Foundation Day of BIRAC , underscoring the sector’s role in healthcare, agriculture, climate mitigation and sustainable manufacturing. Key Developments Target of $300 bn by 2030 – The government aims to reach this milestone through a robust ecosystem of scientists, entrepreneurs and policy support. BioE3 Policy launch – The BioE3 Policy will boost precision biotherapeutics, smart proteins, climate‑resilient crops, bio‑based chemicals and carbon‑capture technologies. RDI Fund allocation – A dedicated RDI Fund of **₹1 lakh crore** places BIRAC at the centre of scaling biotech ventures. Infrastructure push – Creation of shared bio‑foundries , Bio‑AI hubs and advanced biomanufacturing platforms. Startup ecosystem – Over **11,800 biotech startups** are now active, driving innovation and job creation. Important Facts The India Bioeconomy Report (IBER) 2026 records a **CAGR of ~18 %** since 2020. The sector contributes **4.8 % of national GDP** (≈$195.3 bn) and has more than **doubled in size** since 2020. Key focus areas under BioE3 include precision biotherapeutics, smart proteins, climate‑resilient agriculture, bio‑based chemicals and carbon capture. Government funding and mentorship have led to commercialization of affordable healthcare solutions and sustainable technologies. UPSC Relevance The rapid expansion of the Bioeconomy touches multiple GS papers. For GS‑III (Economy) it illustrates a high‑growth sector contributing to GDP, employment and export potential. For GS‑II (Polity) the role of ministries, BIRAC and policy instruments like the BioE3 Policy demonstrate governance for innovation. For GS‑IV (Ethics) the emphasis on inclusive talent development, especially from tier‑2/3 cities and women entrepreneurs, aligns with equitable growth objectives. Way Forward Strengthen public‑private partnerships to accelerate scale‑up of promising biotech products. Expand shared infrastructure like bio‑foundries across regions to reduce geographic disparity. Enhance skill development programmes targeting youth in tier‑2/3 cities to sustain the talent pipeline. Monitor and evaluate the impact of the RDI Fund to ensure efficient capital deployment. Promote export‑oriented biotech clusters to improve trade balance and global competitiveness. Collectively, these measures aim to cement India’s position as a leading global biotech hub and achieve the **$300 bn bioeconomy target by 2030**, thereby supporting the nation’s self‑reliant development agenda.
Quick Reference
Key Insight
BioE3 policy and ₹1 lakh‑crore RDI fund aim to push India's bioeconomy to $300 bn by 2030.
Key Facts
- India's bioeconomy reached $195 bn in 2025, accounting for ~4.8% of GDP.
- The sector has grown at 17‑18% annually since 2014, with a CAGR of ~18% since 2020.
- Government aims to expand the bioeconomy to $300 bn by 2030.
- BioE3 Policy focuses on precision biotherapeutics, smart proteins, climate‑resilient crops, bio‑based chemicals and carbon‑capture technologies.
- A dedicated RDI Fund of ₹1 lakh crore has been allocated, with BIRAC as the nodal agency for scaling biotech ventures.
- India hosts over 11,800 biotech startups driving innovation and employment.
- Infrastructure push includes shared bio‑foundries and Bio‑AI hubs to lower capital barriers.
Background
The rapid expansion of India's bioeconomy aligns with GS‑III themes of high‑growth sectors contributing to GDP, employment and export potential, while the policy framework (BioE3, RDI Fund, BIRAC) illustrates GS‑II governance mechanisms for fostering innovation and sustainable development.
UPSC Syllabus
- Essay — Economy, Development and Inequality
- Essay — Science, Technology and Society
- GS3 — Developments in science and technology and their applications
- GS2 — Government policies and interventions for development
- GS2 — Functions and responsibilities of Union and States
- GS3 — Indian Economy - Planning, mobilization of resources, growth, development and employment
Mains Angle
GS‑III (Economy) – Evaluate how the BioE3 policy and RDI fund can propel the bioeconomy to achieve the $300 bn target by 2030 and its implications for self‑reliant India.